SPY230
/ Spyre Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 05, 2025
Additionally, we are pleased to share new preclinical data demonstrating that each of our combination programs (α4β7 + TL1A, α4β7 + IL-23, and TL1A + IL-23) exhibit superior efficacy relative to constituent monotherapies in rodent TNBS-induced colitis models...
(GlobeNewswire)
- "The poster will be available for viewing during the UEGW Congress..."
Preclinical • Inflammatory Bowel Disease • Ulcerative Colitis
1 to 1
Of
1
Go to page
1